Cargando…
Metabolic Signaling to Epigenetic Alterations in Cancer
Cancer cells reprogram cellular metabolism to support the malignant features of tumors, such as rapid growth and proliferation. The cancer promoting effects of metabolic reprogramming are found in many aspects: generating additional energy, providing more anabolic molecules for biosynthesis, and reb...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746039/ https://www.ncbi.nlm.nih.gov/pubmed/29212308 http://dx.doi.org/10.4062/biomolther.2017.185 |
_version_ | 1783289030306168832 |
---|---|
author | Kim, Jung-Ae Yeom, Young Il |
author_facet | Kim, Jung-Ae Yeom, Young Il |
author_sort | Kim, Jung-Ae |
collection | PubMed |
description | Cancer cells reprogram cellular metabolism to support the malignant features of tumors, such as rapid growth and proliferation. The cancer promoting effects of metabolic reprogramming are found in many aspects: generating additional energy, providing more anabolic molecules for biosynthesis, and rebalancing cellular redox states in cancer cells. Metabolic pathways are considered the pipelines to supply metabolic cofactors of epigenetic modifiers. In this regard, cancer metabolism, whereby cellular metabolite levels are greatly altered compared to normal levels, is closely associated with cancer epigenetics, which is implicated in many stages of tumorigenesis. In this review, we provide an overview of cancer metabolism and its involvement in epigenetic modifications and suggest that the metabolic adaptation leading to epigenetic changes in cancer cells is an important non-genetic factor for tumor progression, which cooperates with genetic causes. Understanding the interaction of metabolic reprogramming with epigenetics in cancers may help to develop novel or highly improved therapeutic strategies that target cancer metabolism. |
format | Online Article Text |
id | pubmed-5746039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Society of Applied Pharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-57460392018-01-01 Metabolic Signaling to Epigenetic Alterations in Cancer Kim, Jung-Ae Yeom, Young Il Biomol Ther (Seoul) Invited Review Cancer cells reprogram cellular metabolism to support the malignant features of tumors, such as rapid growth and proliferation. The cancer promoting effects of metabolic reprogramming are found in many aspects: generating additional energy, providing more anabolic molecules for biosynthesis, and rebalancing cellular redox states in cancer cells. Metabolic pathways are considered the pipelines to supply metabolic cofactors of epigenetic modifiers. In this regard, cancer metabolism, whereby cellular metabolite levels are greatly altered compared to normal levels, is closely associated with cancer epigenetics, which is implicated in many stages of tumorigenesis. In this review, we provide an overview of cancer metabolism and its involvement in epigenetic modifications and suggest that the metabolic adaptation leading to epigenetic changes in cancer cells is an important non-genetic factor for tumor progression, which cooperates with genetic causes. Understanding the interaction of metabolic reprogramming with epigenetics in cancers may help to develop novel or highly improved therapeutic strategies that target cancer metabolism. The Korean Society of Applied Pharmacology 2018-01 2017-12-07 /pmc/articles/PMC5746039/ /pubmed/29212308 http://dx.doi.org/10.4062/biomolther.2017.185 Text en Copyright ©2018, The Korean Society of Applied Pharmacology http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Invited Review Kim, Jung-Ae Yeom, Young Il Metabolic Signaling to Epigenetic Alterations in Cancer |
title | Metabolic Signaling to Epigenetic Alterations in Cancer |
title_full | Metabolic Signaling to Epigenetic Alterations in Cancer |
title_fullStr | Metabolic Signaling to Epigenetic Alterations in Cancer |
title_full_unstemmed | Metabolic Signaling to Epigenetic Alterations in Cancer |
title_short | Metabolic Signaling to Epigenetic Alterations in Cancer |
title_sort | metabolic signaling to epigenetic alterations in cancer |
topic | Invited Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746039/ https://www.ncbi.nlm.nih.gov/pubmed/29212308 http://dx.doi.org/10.4062/biomolther.2017.185 |
work_keys_str_mv | AT kimjungae metabolicsignalingtoepigeneticalterationsincancer AT yeomyoungil metabolicsignalingtoepigeneticalterationsincancer |